Keros Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $236k | 5.9k | 39.76 |
| 2023-09-30 | $486k | 15k | 31.88 |
| 2023-06-30 | $857k | 21k | 40.18 |
| 2022-12-31 | $2.3k | 47 | 48.02 |
| 2022-09-30 | $24k | 665 | 36.30 |
| 2022-06-30 | $115k | 4.2k | 27.46 |
| 2022-03-31 | $81k | 1.5k | 54.63 |
| 2021-12-31 | $400k | 6.8k | 58.53 |
| 2021-09-30 | $0 | 3 | 0.00 |
| 2021-06-30 | $0 | 9 | 0.00 |
| 2021-03-31 | $27k | 431 | 62.65 |
| 2020-12-31 | $1.4M | 20k | 70.53 |
| 2020-09-30 | $482k | 13k | 38.46 |
| 2020-06-30 | $452k | 12k | 37.56 |